Skip to content
Trial Eligibility
Menu

Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.

NCT05721027

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This will be a placebo controlled, randomized, double-blind, comparative effectiveness study, in which we patients are enrolled during an emergency department (ED) visit for acute radicular low back pain (LBP) and followed by telephone two and seven days later. Patients will be randomized to receive an oral dose of dexamethasone for 2 consecutive days or placebo during an ED visit for acute radicular LBP. Every patient will receive a 7 day supply of ibuprofen and a low back pain education session.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Radiculopathy, Lumbosacral Region
  • Back Pain With Radiation
  • Low Back Pain

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Montefiore Medical Center
Last updated on ClinicalTrials.gov
April 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 2

  • Albert Einstein College of Medicine/Montefiore Medical Center - Weiler ED · The Bronx, NY
  • Montefiore Medical Center - Moses ED · The Bronx, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.